Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder

NCT01023269 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT01023269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01023269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV, Multi-center, Randomized, Cross-over Study to Demonstrate the Efficacy of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder
Lead sponsor
MedtronicNeuro
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2009
Completion date
June 30, 2012
Enrollment
17 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

detrusor overactivity, neurogenic overactive bladder, urinary incontinence